November #86 : Tot Trials - by Katie Krauss

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join

Back to home » Archives » POZ Magazine issues

Table of Contents

Special Report: Takin' It to the Street

Special Report: Dangerous Council

Special Report: New Enemies List...

...And a Few Allies?

Magical Math

Tot Trials

Wan Free!

Talking Turkey

Faster, Pussycat, Die, Die!

Abbott On The Spot

IV in Vain:

Prison Plus:

Ahoy, New Meds Ahead!

Face It:

Vile Bodies:

Deep Kissing in the Deep South

Lip Service




Curiosity Thrills This Cat

Special Report:A Declaration of War

Most Popular Lessons

The HIV Life Cycle


Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

email print

November 2002

Tot Trials

by Katie Krauss

My daughter's been on HIV medication for 13 years, since she was born," said Jan K. "She was severely ill from some of the medications. She's been through four regimens. Her growth has been affected, and her walking. All the drugs have such a strong effect on them. That's why this research is crucial."

Why the plaintive plug for research on kids with HIV? Because the Pediatric AIDS Clinical Trials Group (PACTG) has been pulling the plug on sites since February, when the National Institute of Allergy and Infectious Diseases (NIAID) quietly announced a five-year grant of $36 million per year -- "flat-funding," a.k.a. cost-cutting. "Overall funding for the PACTG has functionally declined in the last three years," said Stephen Spector, MD, the group's chair.

A "disappointed" Paul Palumbo, MD, PACTG vice-chair, said, "We're one of the few networks targeting children that can help jump-start trials in the developing world." Stretching their dollars to open sites in South Africa and Thailand, the feds defunded four clinical-trial units at home, causing a chain reaction that closed 10 pediatric sites. Pissed parents like Jan K. are complaining not that the global AIDS program is sucking up bucks that should go to American HIVers, but that NIAID, a $2 billion agency, could easily have found the $4 million to bridge the gap.

Penny-wise, pound-foolish? So says Spector: "The funding situation also has the potential to discourage young investigators from going into the field of pediatric research." That's troubling, because basic life-and-death questions persist about how to treat HIV in the nation's 9,000 infected children under 15: Even HAART dosing is being debated. The federal government will conduct an annual review of the PACTG funding early next year.

[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Has a pet helped you deal with your HIV?


more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2016 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.